المؤلفون: Giannakopoulou, E, Lehander, M, Culleton, SV, Yang, WW, Li, YQ, Karpanen, T, Yoshizato, T, Rustad, EH, Nielsen, MM, Bollineni, RC, Tran, TT, Delic-Sarac, M, Gjerdingen, TJ, Douvlataniotis, K, Laos, M, Ali, M, Hillen, A, Mazzi, S, Chin, DWL, Mehta, A, Holm, JS, Bentzen, AK, Bill, M, Griffioen, M, Gedde-Dahl, T, Lehmann, S, Jacobsen, SEW, Woll, PS, Olweus, J

المصدر: Nature cancer. 4(11):1474-1490

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154009455

المؤلفون: Kristensen NP; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Dionisio E; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Bentzen AK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Tamhane T; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Kemming JS; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Nos G; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Voss LF; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Hansen UK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Lauer GM; Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Hadrup SR; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark.

المصدر: Science advances [Sci Adv] 2024 Apr 12; Vol. 10 (15), pp. eadm8951. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: Epitopes, T-Lymphocyte* , CD8-Positive T-Lymphocytes*, Humans ; Alleles ; Down-Regulation ; Peptides

المؤلفون: Hansen UK; Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Church CD; Department of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA., Carnaz Simões AM; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Frej MS; Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Bentzen AK; Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Tvingsholm SA; Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Becker JC; Department of Translational Skin Cancer Research, University Hospital Essen and German Cancer Consortium (DKTK), Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, University Hospital Essen, Essen, Germany., Fling SP; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Ramchurren N; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Topalian SL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Nghiem PT; Department of Dermatology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hadrup SR; Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Jan 30; Vol. 134 (8). Date of Electronic Publication: 2024 Jan 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Merkel Cell*/drug therapy , Carcinoma, Merkel Cell*/genetics , Skin Neoplasms*/drug therapy , Skin Neoplasms*/genetics, Humans ; Antigens, Viral, Tumor ; Programmed Cell Death 1 Receptor/genetics ; CD8-Positive T-Lymphocytes

المؤلفون: Tvingsholm SA; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Frej MS; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Rafa VM; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Hansen UK; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Ormhøj M; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Tyron A; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Jensen AWP; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Kadivar M; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Bentzen AK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Munk KK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Aasbjerg GN; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Ternander JSH; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark., Heeke C; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Tamhane T; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Schmess C; NMI Natural and Medical Science Institute, University of Tübingen, Tubingen, Germany., Funt SA; Deptartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Kverneland AH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Copenhagen, Denmark., Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Jakobsen SN; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Marie Svane I; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark sirha@dtu.dk.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/therapy , Neoplasms, Second Primary*, Humans ; Immunotherapy, Adoptive ; Leukocytes, Mononuclear ; Cytokines ; Receptors, Antigen, T-Cell

المؤلفون: Povlsen HR; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark., Bentzen AK; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark., Kadivar M; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark., Jessen LE; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark., Hadrup SR; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark., Nielsen M; Department of Health Technology at Technical University of Denmark, Kongens Lyngby, Denmark.

المصدر: ELife [Elife] 2023 May 03; Vol. 12. Date of Electronic Publication: 2023 May 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Antigen, T-Cell*/genetics , T-Lymphocytes*, Antigens ; Peptides

المؤلفون: Holm JS; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Borch A; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Munk KK; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Bjerregaard AM; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Reading JL; Cancer Immunology Unit, Research Department of Hematology and Cancer Research UK, Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Maher C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Regazzi A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Wong P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Al-Ahmadie H; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iyer G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Tamhane T; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Bentzen AK; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Herschend NO; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., De Wolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Snyder A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Merghoub T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Nielsen M; Section of Bioinformatics, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Bajorin DF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, New York, NY, 10065, USA., Hadrup SR; Experimental and Translational Immunology, Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark. sirha@dtu.dk.

المصدر: Nature communications [Nat Commun] 2022 Apr 11; Vol. 13 (1), pp. 1935. Date of Electronic Publication: 2022 Apr 11.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/genetics , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/genetics, B7-H1 Antigen/genetics ; CD8-Positive T-Lymphocytes ; Humans ; Immune Checkpoint Inhibitors

المؤلفون: Kristensen NP; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Heeke C; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Tvingsholm SA; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Borch A; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Crowther MD; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Carri I; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina., Munk KK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Holm JS; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Bjerregaard AM; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Bentzen AK; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Marquard AM; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark., Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark., McGranahan N; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom., Andersen R; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Nielsen M; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina.; Section for Bioinformatics, Department of Health Technology, DTU, Kongens Lyngby, Denmark., Jönsson GB; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Hadrup SR; Section for Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark.

المصدر: The Journal of clinical investigation [J Clin Invest] 2022 Jan 18; Vol. 132 (2).

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Adoptive Transfer* , Lymphocyte Activation* , Melanoma*/immunology , Melanoma*/therapy, Antigens, Neoplasm/*immunology , CD8-Positive T-Lymphocytes/*immunology , Lymphocytes, Tumor-Infiltrating/*immunology, Female ; Humans ; Male

المؤلفون: Montemurro A; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Schuster V; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Povlsen HR; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Bentzen AK; Department of Health Technology, Section for Experimental and Translational Immunology, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Jurtz V; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Chronister WD; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Crinklaw A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Hadrup SR; Department of Health Technology, Section for Experimental and Translational Immunology, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Winther O; Department of Biology, Bioinformatics Centre, University of Copenhagen, 2200, Copenhagen, Denmark.; Section for Cognitive Systems, Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kgs., Lyngby, 2800, Denmark.; Centre for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, København, Ø 2100, Denmark., Peters B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, 92037, USA., Jessen LE; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark., Nielsen M; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DTU, 2800 Kgs, Lyngby, Denmark. morni@dtu.dk.; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, Argentina. morni@dtu.dk.

المصدر: Communications biology [Commun Biol] 2021 Sep 10; Vol. 4 (1), pp. 1060. Date of Electronic Publication: 2021 Sep 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Neural Networks, Computer*, Receptors, Antigen, T-Cell/*chemistry, Protein Binding

المؤلفون: Saini SK; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Ørskov AD; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Bjerregaard AM; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Unnikrishnan A; Adult Cancer Program, Lowy Cancer Research Centre, UNSW, Sydney, NSW, 2052, Australia.; Prince of Wales Clinical School, UNSW, Sydney, NSW, 2052, Australia., Holmberg-Thydén S; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark.; Department of Haematology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark., Borch A; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Jensen KV; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Anande G; Adult Cancer Program, Lowy Cancer Research Centre, UNSW, Sydney, NSW, 2052, Australia.; Prince of Wales Clinical School, UNSW, Sydney, NSW, 2052, Australia., Bentzen AK; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Marquard AM; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Tamhane T; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark., Treppendahl MB; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Gang AO; Department of Haematology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark., Dufva IH; Department of Haematology, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark., Szallasi Z; Department of Health Technology, Section of Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark.; Computational Health Informatics Program (CHIP), Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Ternette N; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pedersen AG; Department of Health Technology, Section of Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark., Eklund AC; Department of Health Technology, Section of Bioinformatics, Technical University of Denmark, Kongens Lyngby, Denmark., Pimanda J; Adult Cancer Program, Lowy Cancer Research Centre, UNSW, Sydney, NSW, 2052, Australia.; Prince of Wales Clinical School, UNSW, Sydney, NSW, 2052, Australia.; Haematology Department, South Eastern Area Laboratory Services, Prince of Wales Hospital, Randwick, NSW, 2031, Australia., Grønbæk K; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark., Hadrup SR; Department of Health Technology, Section of Experimental and Translational Immunology, Technical University of Denmark, Kongens Lyngby, Denmark. sirha@dtu.dk.

المصدر: Nature communications [Nat Commun] 2020 Nov 09; Vol. 11 (1), pp. 5660. Date of Electronic Publication: 2020 Nov 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Endogenous Retroviruses/*genetics , Hematologic Neoplasms/*virology , T-Lymphocytes/*metabolism , T-Lymphocytes/*virology, CD8-Positive T-Lymphocytes ; Epigenesis, Genetic ; Epitopes, T-Lymphocyte ; Gene Expression Profiling ; Hematologic Neoplasms/genetics ; Hematologic Neoplasms/therapy ; Humans ; Immunotherapy ; Monitoring, Immunologic ; Myeloid Cells ; Neoplasms

المؤلفون: Hansen UK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Ramskov S; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Bjerregaard AM; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Borch A; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Andersen R; Center for Cancer Immune Therapy, Copenhagen University Hospital, Copenhagen, Denmark., Draghi A; Center for Cancer Immune Therapy, Copenhagen University Hospital, Copenhagen, Denmark., Donia M; Center for Cancer Immune Therapy, Copenhagen University Hospital, Copenhagen, Denmark., Bentzen AK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Marquard AM; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark., Eklund AC; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Clinical Microbiomics A/S, Copenhagen, Denmark., Svane IM; Center for Cancer Immune Therapy, Copenhagen University Hospital, Copenhagen, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

المصدر: Frontiers in immunology [Front Immunol] 2020 Mar 12; Vol. 11, pp. 373. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*immunology , Carcinoma, Renal Cell/*immunology , Kidney Neoplasms/*immunology , Lymphocytes, Tumor-Infiltrating/*immunology , T-Lymphocytes/*immunology, Antigens, Neoplasm/genetics ; Carcinoma, Renal Cell/genetics ; Epitopes, T-Lymphocyte/genetics ; Epitopes, T-Lymphocyte/immunology ; Frameshift Mutation ; Humans ; Kidney Neoplasms/genetics ; Point Mutation